Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulp Response to Castor Oil Versus Formocresol as Pulpotomy Medicaments in Primary Teeth
NCT05723900Completed
- Sponsor
- Tanta University
- Start
- Sep 2022
- Primary completion
- Oct 2022
- Modality
- Small Molecules, Lipid-based Nanoparticles
- Countries
- 1
01
Overview
Randomised trial of Castor oil in pulpitis (2 arms), sponsored by Tanta University. Primary endpoints: Degree of pulp inflammation at 3 months and Presence or absence of dentin chips formation at 3 months. Started Sep 2022; status: completed.
02
Drugs
Castor oil
03
Conditions
pulpitis
Beyond the preview
Go deeper on NCT05723900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05723900.